Page last updated: 2024-08-17

17-alpha-hydroxyprogesterone and Diabetes Mellitus, Type 2

17-alpha-hydroxyprogesterone has been researched along with Diabetes Mellitus, Type 2 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Chernova, MO; Ioutsi, VA; Mel'nichenko, GA; Mokrysheva, NG; Rozhivanov, RV; Shestakova, MV1
Chen, Y; Hu, C; Jiang, J; Li, X; Liu, B; Lu, Y; Lu, Z; Qian, Y; Wang, E; Wu, D; Xiang, L; Xiong, X; Yan, J; Zhang, H; Zhang, R; Zhao, J; Zhao, L; Zhou, B1
Krysiak, R; Okopien, B1
Bozic, R; Carani, C; Granata, AR; Pacchioni, C; Pignatti, E; Rochira, V; Roli, L; Santi, D; Simoni, M; Trenti, T; Zaza, S1
Sacerdote, AS1

Trials

1 trial(s) available for 17-alpha-hydroxyprogesterone and Diabetes Mellitus, Type 2

ArticleYear
Effects of chronic administration of the phosphodiesterase inhibitor vardenafil on serum levels of adrenal and testicular steroids in men with type 2 diabetes mellitus.
    Endocrine, 2017, Volume: 56, Issue:2

    Topics: 17-alpha-Hydroxyprogesterone; Androgens; Androstenedione; Chromatography, Liquid; Corticosterone; Diabetes Mellitus, Type 2; Double-Blind Method; Humans; Hydrocortisone; Longitudinal Studies; Male; Middle Aged; Progesterone; Prospective Studies; Tandem Mass Spectrometry; Testosterone; Vardenafil Dihydrochloride

2017

Other Studies

4 other study(ies) available for 17-alpha-hydroxyprogesterone and Diabetes Mellitus, Type 2

ArticleYear
[Features of steroidogenesis in men with hypogonadism and type 2 diabetes].
    Problemy endokrinologii, 2022, 06-16, Volume: 68, Issue:3

    Topics: 17-alpha-Hydroxyprogesterone; Androgens; Cross-Sectional Studies; Dehydroepiandrosterone; Diabetes Mellitus, Type 2; Humans; Hypogonadism; Male; Testosterone

2022
Obesity-induced excess of 17-hydroxyprogesterone promotes hyperglycemia through activation of glucocorticoid receptor.
    The Journal of clinical investigation, 2020, 07-01, Volume: 130, Issue:7

    Topics: 17-alpha-Hydroxyprogesterone; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Female; Humans; Hyperglycemia; Liver; Male; Mice; Obesity; Receptors, Glucocorticoid; Signal Transduction; Steroid 17-alpha-Hydroxylase

2020
The effect of metformin on androgen production in diabetic women with non-classic congenital adrenal hyperplasia.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2014, Volume: 122, Issue:10

    Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adult; Androgens; Blood Glucose; Dehydroepiandrosterone; Diabetes Mellitus, Type 2; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Metformin; Middle Aged; Testosterone; Treatment Outcome

2014
Adrenal androgens and NIDDM.
    Diabetes care, 1995, Volume: 18, Issue:2

    Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adult; Aged; Aged, 80 and over; Androgens; Cosyntropin; Dexamethasone; Diabetes Mellitus; Diabetes Mellitus, Type 2; Estrogens; Female; Humans; Hydroxyprogesterones; Male; Middle Aged; Obesity; Premenopause

1995